{"id":7968,"date":"2025-12-01T08:48:51","date_gmt":"2025-12-01T06:48:51","guid":{"rendered":"https:\/\/olpha.eu\/?p=7968"},"modified":"2025-12-01T08:48:52","modified_gmt":"2025-12-01T06:48:52","slug":"olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment","status":"publish","type":"post","link":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/","title":{"rendered":"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">To ensure the production volumes foreseen in its development plans, AS <em>Olpha<\/em>, one of the leading pharmaceutical manufacturers in the Baltic region, has purchased and installed new manufacturing equipment worth a total of 4.4 million euros. In total, four new machines have been installed as part of the project, which will significantly increase production capacity, given that in the coming years the company plans to offer at least 50 new generic medicines in European, UK, and other global markets.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This autumn, a new blistering and packaging line was launched, with an investment of more than 2.5 million euros. In addition, a compactor\u2014equipment used for producing dry granulated dosage forms\u2014was installed for 356,750 euros. Another 800,000 euros were invested in the purchase of a new tablet coating drum, and a further 700,000 euros were spent on installing a new capsule-filling machine. The total investment received state support covering 30% of the equipment acquisition costs under the support programme \u201cLarge Investment Loan with Capital Rebate,\u201d in cooperation with the Latvian Investment and Development Agency and the Development Finance Institution ALTUM.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cOne of our priorities is to achieve greener, more efficient, and more sustainable production processes. Furthermore, as the labour market situation becomes increasingly strained, the automation of production and packaging processes is inevitable. This allows us to ensure the necessary production volumes and efficiency throughout the process. Since our ambition is to continue developing and strengthening pharmaceutical manufacturing in Latvia\u2014an industry with high added value for the national economy and significant export potential\u2014we are making the necessary investments to achieve these goals,\u201d emphasizes Juris Bundulis, Chairman of the Board of AS <em>Olpha<\/em>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The new coating drum and capsule-filling machine make it possible to double production capacity. Previously, 42,000 capsules could be produced per hour, while the new capsule-filling machine allows for the production of 84,000.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cOur strategy is built on three core values\u2014sustainability, innovation, and strengthening export capacity. By investing in modern production equipment, green energy, and digitalization, we are strengthening <em>Olpha\u2019s<\/em> competitiveness and creating significant value for the Latvian economy. At the same time, as a local pharmaceutical manufacturer, we see an opportunity to reduce Latvia\u2019s import dependence by expanding our product portfolio. Currently, 95% of medicines in Latvia are imported, which poses high risks for every patient in cases of supply disruptions. Therefore, Latvia\u2019s pharmaceutical and medicine manufacturing sector must be purposefully developed\u2014no other Baltic country, neither Lithuania nor Estonia, has it at such an advanced level,\u201d stresses J. Bundulis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It should be added that, according to the company\u2019s long-term development strategy, AS <em>Olpha<\/em> plans to invest 100 million euros over a five-year period in the development of its product portfolio, modernization of production equipment, capacity expansion for new product launches, and advancement of \u201cgreen\u201d technological processes. The largest share of the investment will go toward developing new generic medicines and expanding the product portfolio.<\/p>\n\n\n\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" data-id=\"7966\" src=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1404-1024x768.jpeg\" alt=\"\" class=\"wp-image-7966\" srcset=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1404-1024x768.jpeg 1024w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1404-300x225.jpeg 300w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1404-768x576.jpeg 768w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1404-1536x1152.jpeg 1536w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1404-2048x1536.jpeg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" data-id=\"7964\" src=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1419-1024x768.jpeg\" alt=\"\" class=\"wp-image-7964\" srcset=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1419-1024x768.jpeg 1024w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1419-300x225.jpeg 300w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1419-768x576.jpeg 768w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1419-1536x1152.jpeg 1536w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1419-2048x1536.jpeg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" data-id=\"7962\" src=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1380-1024x768.jpeg\" alt=\"\" class=\"wp-image-7962\" srcset=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1380-1024x768.jpeg 1024w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1380-300x225.jpeg 300w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1380-768x576.jpeg 768w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1380-1536x1152.jpeg 1536w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1380-2048x1536.jpeg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" data-id=\"7960\" src=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1398-768x1024.jpeg\" alt=\"\" class=\"wp-image-7960\" srcset=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1398-768x1024.jpeg 768w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1398-225x300.jpeg 225w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1398-1152x1536.jpeg 1152w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1398-1536x2048.jpeg 1536w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1398-scaled.jpeg 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" data-id=\"7958\" src=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1399-1024x768.jpeg\" alt=\"\" class=\"wp-image-7958\" srcset=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1399-1024x768.jpeg 1024w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1399-300x225.jpeg 300w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1399-768x576.jpeg 768w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1399-1536x1152.jpeg 1536w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1399-2048x1536.jpeg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" data-id=\"7956\" src=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1423-768x1024.jpeg\" alt=\"\" class=\"wp-image-7956\" srcset=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1423-768x1024.jpeg 768w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1423-225x300.jpeg 225w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1423-1152x1536.jpeg 1152w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1423-1536x2048.jpeg 1536w, https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1423-scaled.jpeg 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/><\/figure>\n<\/figure>\n","protected":false},"excerpt":{"rendered":"<p>To ensure the production volumes foreseen in its development plans, AS Olpha, one of the leading pharmaceutical manufacturers in the Baltic region, has purchased and installed new manufacturing equipment worth a total of 4.4 million euros. In total, four new machines have been installed as part of the project, which will significantly increase production capacity, [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":7954,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7968","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment - Olpha<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment - Olpha\" \/>\n<meta property=\"og:description\" content=\"To ensure the production volumes foreseen in its development plans, AS Olpha, one of the leading pharmaceutical manufacturers in the Baltic region, has purchased and installed new manufacturing equipment worth a total of 4.4 million euros. In total, four new machines have been installed as part of the project, which will significantly increase production capacity, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/\" \/>\n<meta property=\"og:site_name\" content=\"Olpha\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OlphaLatvia\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-01T06:48:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-01T06:48:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liga\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/\"},\"author\":{\"name\":\"Liga\",\"@id\":\"https:\/\/olpha.eu\/en\/#\/schema\/person\/061ae2165b5c60fcdba91494ec61cc8f\"},\"headline\":\"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment\",\"datePublished\":\"2025-12-01T06:48:51+00:00\",\"dateModified\":\"2025-12-01T06:48:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/\"},\"wordCount\":483,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/olpha.eu\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/\",\"url\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/\",\"name\":\"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment - Olpha\",\"isPartOf\":{\"@id\":\"https:\/\/olpha.eu\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg\",\"datePublished\":\"2025-12-01T06:48:51+00:00\",\"dateModified\":\"2025-12-01T06:48:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#primaryimage\",\"url\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg\",\"contentUrl\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg\",\"width\":2560,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/olpha.eu\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/olpha.eu\/en\/#website\",\"url\":\"https:\/\/olpha.eu\/en\/\",\"name\":\"Olpha\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/olpha.eu\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/olpha.eu\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/olpha.eu\/en\/#organization\",\"name\":\"Olpha\",\"url\":\"https:\/\/olpha.eu\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/olpha.eu\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2024\/06\/OLPHA_logo-1.svg\",\"contentUrl\":\"https:\/\/olpha.eu\/wp-content\/uploads\/2024\/06\/OLPHA_logo-1.svg\",\"width\":1,\"height\":1,\"caption\":\"Olpha\"},\"image\":{\"@id\":\"https:\/\/olpha.eu\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/OlphaLatvia\",\"https:\/\/instagram.com\/olphalatvia\",\"https:\/\/www.linkedin.com\/company\/OlphaGlobal\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/olpha.eu\/en\/#\/schema\/person\/061ae2165b5c60fcdba91494ec61cc8f\",\"name\":\"Liga\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/f6028465db3a088d026c911a57e9ffe4b7c82fded56cf5fd799a3f00abb841fe?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f6028465db3a088d026c911a57e9ffe4b7c82fded56cf5fd799a3f00abb841fe?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f6028465db3a088d026c911a57e9ffe4b7c82fded56cf5fd799a3f00abb841fe?s=96&d=mm&r=g\",\"caption\":\"Liga\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment - Olpha","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/","og_locale":"en_US","og_type":"article","og_title":"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment - Olpha","og_description":"To ensure the production volumes foreseen in its development plans, AS Olpha, one of the leading pharmaceutical manufacturers in the Baltic region, has purchased and installed new manufacturing equipment worth a total of 4.4 million euros. In total, four new machines have been installed as part of the project, which will significantly increase production capacity, [&hellip;]","og_url":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/","og_site_name":"Olpha","article_publisher":"https:\/\/www.facebook.com\/OlphaLatvia","article_published_time":"2025-12-01T06:48:51+00:00","article_modified_time":"2025-12-01T06:48:52+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg","type":"image\/jpeg"}],"author":"Liga","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#article","isPartOf":{"@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/"},"author":{"name":"Liga","@id":"https:\/\/olpha.eu\/en\/#\/schema\/person\/061ae2165b5c60fcdba91494ec61cc8f"},"headline":"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment","datePublished":"2025-12-01T06:48:51+00:00","dateModified":"2025-12-01T06:48:52+00:00","mainEntityOfPage":{"@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/"},"wordCount":483,"commentCount":0,"publisher":{"@id":"https:\/\/olpha.eu\/en\/#organization"},"image":{"@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#primaryimage"},"thumbnailUrl":"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/","url":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/","name":"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment - Olpha","isPartOf":{"@id":"https:\/\/olpha.eu\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#primaryimage"},"image":{"@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#primaryimage"},"thumbnailUrl":"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg","datePublished":"2025-12-01T06:48:51+00:00","dateModified":"2025-12-01T06:48:52+00:00","breadcrumb":{"@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#primaryimage","url":"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg","contentUrl":"https:\/\/olpha.eu\/wp-content\/uploads\/2025\/12\/IMG_1408-1-scaled.jpeg","width":2560,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/olpha.eu\/en\/olpha-invests-4-4-million-euros-in-new-pharmaceutical-manufacturing-equipment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/olpha.eu\/en\/"},{"@type":"ListItem","position":2,"name":"\u201cOlpha\u201d invests 4.4 million euros in new pharmaceutical manufacturing equipment"}]},{"@type":"WebSite","@id":"https:\/\/olpha.eu\/en\/#website","url":"https:\/\/olpha.eu\/en\/","name":"Olpha","description":"","publisher":{"@id":"https:\/\/olpha.eu\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/olpha.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/olpha.eu\/en\/#organization","name":"Olpha","url":"https:\/\/olpha.eu\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olpha.eu\/en\/#\/schema\/logo\/image\/","url":"https:\/\/olpha.eu\/wp-content\/uploads\/2024\/06\/OLPHA_logo-1.svg","contentUrl":"https:\/\/olpha.eu\/wp-content\/uploads\/2024\/06\/OLPHA_logo-1.svg","width":1,"height":1,"caption":"Olpha"},"image":{"@id":"https:\/\/olpha.eu\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OlphaLatvia","https:\/\/instagram.com\/olphalatvia","https:\/\/www.linkedin.com\/company\/OlphaGlobal"]},{"@type":"Person","@id":"https:\/\/olpha.eu\/en\/#\/schema\/person\/061ae2165b5c60fcdba91494ec61cc8f","name":"Liga","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f6028465db3a088d026c911a57e9ffe4b7c82fded56cf5fd799a3f00abb841fe?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f6028465db3a088d026c911a57e9ffe4b7c82fded56cf5fd799a3f00abb841fe?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f6028465db3a088d026c911a57e9ffe4b7c82fded56cf5fd799a3f00abb841fe?s=96&d=mm&r=g","caption":"Liga"}}]}},"_links":{"self":[{"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/posts\/7968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/comments?post=7968"}],"version-history":[{"count":1,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/posts\/7968\/revisions"}],"predecessor-version":[{"id":7969,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/posts\/7968\/revisions\/7969"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/media\/7954"}],"wp:attachment":[{"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/media?parent=7968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/categories?post=7968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/olpha.eu\/en\/wp-json\/wp\/v2\/tags?post=7968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}